You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Meropenem - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for meropenem and what is the scope of freedom to operate?

Meropenem is the generic ingredient in four branded drugs marketed by Acs Dobfar, Acs Dobfar Spa, Amneal Pharms, Brooks Steriscience, Daewoong Pharm Co, Eugia Pharma, Gland, Hospira Inc, Hq Spclt Pharma, Qilu, Sandoz, Savior Lifetec Corp, Pfizer, B Braun Medical Inc, and Rempex, and is included in sixteen NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for meropenem. Fifteen suppliers are listed for this compound.

Summary for meropenem
Drug Prices for meropenem

See drug prices for meropenem

Recent Clinical Trials for meropenem

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Scandinavian Critical Care Trials GroupPhase 4
Pisa University HospitalPhase 4
Sheba Medical CenterPhase 4

See all meropenem clinical trials

Pharmacology for meropenem

US Patents and Regulatory Information for meropenem

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eugia Pharma MEROPENEM meropenem INJECTABLE;INJECTION 205835-002 Mar 27, 2017 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rempex VABOMERE meropenem; vaborbactam POWDER;INTRAVENOUS 209776-001 Aug 29, 2017 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
B Braun Medical Inc MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER meropenem POWDER;INTRAVENOUS 202106-001 Apr 30, 2015 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
B Braun Medical Inc MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER meropenem POWDER;INTRAVENOUS 202106-002 Apr 30, 2015 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hq Spclt Pharma MEROPENEM meropenem POWDER;INTRAVENOUS 215212-001 Jul 26, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hq Spclt Pharma MEROPENEM meropenem INJECTABLE;INJECTION 210773-002 Aug 16, 2019 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.